NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare rigorously for the NAPLEX, the pivotal examination for pharmacy licensure! Gain confidence with expertly crafted quizzes and study materials tailored for aspiring pharmacists. Elevate your understanding and skills today!

Practice this question and more.


Which of the following is NOT a warning for Kineret?

  1. Malignancies

  2. Serious infections

  3. HBV reactivation

  4. Cardiac failure

The correct answer is: HBV reactivation

Kineret is an interleukin-1 receptor antagonist used to treat rheumatoid arthritis. One of the warnings associated with Kineret is the risk of reactivation of hepatitis B virus (HBV) in patients who are carriers. This reactivation can lead to serious liver problems. Therefore, option C, HBV reactivation, is NOT a warning for Kineret. Options A, B, and D are warnings associated with Kineret. Malignancies, serious infections, and cardiac failure are all potential risks or warnings that should be considered when prescribing or using Kineret.